Li Xinyi, Xiao Yuyang, Yang Meng, Zhang Xupeng, Yuan Zhangchi, Zhang Zaiqiu, Zhang Hanyong, Liu Lin, Zhao Mingyi
Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410013, People's Republic of China.
Development of Novel Pharmaceutical Preparations, Changsha Medical University, Changsha, 410219, People's Republic of China.
Int J Chron Obstruct Pulmon Dis. 2025 May 28;20:1761-1786. doi: 10.2147/COPD.S510846. eCollection 2025.
Evidence suggests a bidirectional association between chronic obstructive pulmonary disease (COPD) and sepsis, but the underlying mechanisms remain unclear. This study aimed to explore shared diagnostic genes, potential mechanisms, and the role of immune cells in the COPD-sepsis relationship using Mendelian randomization (MR) and bioinformatics approaches, while also identifying potential therapeutic drugs.
Two-sample MR analysis was performed using genome-wide association data to assess genetically predicted COPD and sepsis. Immune cell-mediated effects were quantified using a two-way two-sample MR analysis. Differential expression gene (DEG) analysis and weighted gene co-expression network analysis (WGCNA) were used to identify common genes. Functional enrichment analyses were conducted to explore the biological roles of these genes. LASSO and SVM-RFE algorithms identified shared diagnostic genes, which were evaluated using receiver operating characteristic (ROC) curves. Immune cell infiltration was analyzed with CIBERSORT, while transcription factor (TF) and miRNA networks were constructed using NetworkAnalyst. Drug predictions were made using DSigDB, and molecular docking validated potential drugs.
Three immune cell types were identified as mediators between COPD and sepsis, with genetically predicted effects mediated by these cells at rates of 6.5%, 12.8%, and 3.9%. A total of 33 overlapping genes were identified, and AIM2 and RNF125 were highlighted as key diagnostic genes. Immune infiltration analysis revealed dysregulated monocyte, macrophage, plasma, and dendritic cells. Regulatory network analysis identified nine key co-regulators. Ten potential drug targets were identified, with seven validated via molecular docking.
AIM2 and RNF125 may serve as diagnostic biomarkers, and identified immune cell subsets could mediate the COPD-sepsis connection, offering insights into potential therapeutic targets.
有证据表明慢性阻塞性肺疾病(COPD)与脓毒症之间存在双向关联,但其潜在机制仍不清楚。本研究旨在利用孟德尔随机化(MR)和生物信息学方法探索COPD与脓毒症之间的共享诊断基因、潜在机制以及免疫细胞的作用,同时确定潜在的治疗药物。
使用全基因组关联数据进行两样本MR分析,以评估基因预测的COPD和脓毒症。使用双向两样本MR分析对免疫细胞介导的效应进行量化。差异表达基因(DEG)分析和加权基因共表达网络分析(WGCNA)用于识别共同基因。进行功能富集分析以探索这些基因的生物学作用。LASSO和SVM-RFE算法识别共享诊断基因,并使用受试者工作特征(ROC)曲线进行评估。使用CIBERSORT分析免疫细胞浸润,同时使用NetworkAnalyst构建转录因子(TF)和miRNA网络。使用DSigDB进行药物预测,并通过分子对接验证潜在药物。
确定了三种免疫细胞类型作为COPD和脓毒症之间的介质,这些细胞介导的基因预测效应发生率分别为6.5%、12.8%和3.9%。共鉴定出33个重叠基因,AIM2和RNF125被突出显示为关键诊断基因。免疫浸润分析显示单核细胞、巨噬细胞、血浆和树突状细胞失调。调控网络分析确定了九个关键共调节因子。确定了十个潜在药物靶点,其中七个通过分子对接得到验证。
AIM2和RNF125可能作为诊断生物标志物,确定的免疫细胞亚群可能介导COPD与脓毒症的联系,为潜在治疗靶点提供见解。